A rare entity: Recurrent cisplatin-induced bradycardia.

Tytuł:: A rare entity: Recurrent cisplatin-induced bradycardia.
Autorzy:: Sagcan F; Department of Pediatrics, Mersin University Faculty of Medicine, Mersin, Turkey.
Citak EC; Department of Pediatric Oncology, Mersin University Faculty of Medicine, Mersin, Turkey.
Karpuz D; Department of Pediatric Oncology, Mersin University Faculty of Medicine, Mersin, Turkey.
Alakaya M; Department of Pediatric Intensive Care Unit, Mersin University Faculty of Medicine, Mersin, Turkey.
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2020 Apr-Jun; Vol. 16 (3), pp. 699-700.
Typ publikacji:: Case Reports; Letter
Język:: English
Imprint Name(s):: Original Publication: Mumbai, India : Medknow Publications
MeSH Terms:: Antineoplastic Agents/*adverse effects
Bradycardia/*chemically induced
Cisplatin/*adverse effects
Nasopharyngeal Carcinoma/*drug therapy
Nasopharyngeal Neoplasms/*drug therapy
Adolescent ; Humans ; Male ; Nasopharyngeal Carcinoma/pathology ; Nasopharyngeal Neoplasms/pathology ; Prognosis
Substance Nomenclature:: 0 (Antineoplastic Agents)
Q20Q21Q62J (Cisplatin)
Entry Date(s):: Date Created: 20200729 Date Completed: 20200923 Latest Revision: 20200923
Update Code:: 20240104
DOI:: 10.4103/jcrt.JCRT_26_18
PMID:: 32719297
: Raport

Full Text Finder

Competing Interests: None

Informacja